drugset / Trial / NCT00995605
AMAP102 - Safety, Tolerability and Pharmacokinetics in Healthy Subjects
RandomizedSingle-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether AMAP102 is safe and well tolerated by humans.
Timeline
- Start
- 2009-04
- Primary completion
- 2009-08
- Completion
- 2009-08
Outcome
Outcome not reported
Stopped: “Reached sufficient pharmacokinetic exposures”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AMAP102 | Unknown | — | Oral |
Indications
No indication recorded.